Medifocus Inc. reported earnings results for the third quarter and nine months ended December 31, 2016. Prolieve® sales were $1,043,335 for the quarter ended December 31, 2016, compared to $1,136,755 for same period in 2015, reflecting a decrease of 8%. However, due to the cost reduction measures implemented under the company's new management since March 2016, the Company achieved its first ever quarterly operating profit of $33,694, compared to a loss of $1,082,397 in the same period in 2015. For the nine months ended December 31, 2016, sales were maintained at $3,170,299, a decrease of 7% from the $3,398,125 in the same period in 2015. Operating losses were reduced significantly under the new program, from $2,676,912 to $239,129, a 91% improvement compared to the same period in 2015.